Neuland Laboratories Limited — Others, 26-08-2025: Shareholders meeting

Neuland Laboratories is conducting a postal ballot to secure shareholder approval for Dr. Ravi Shankar Gopinath's appointment as an Independent Director. The Board had previously onboarded him as an Additional Director. His significant background in strategy formulation, digital technologies, operational excellence, and M&A is expected to provide substantial value. The Board endorses his five-year term, during which he will not be subject to retirement by rotation. Shareholders can participate by remote e-voting.